KPWHRI_News_masthead_website2.jpg

august 2020

Covid-19-vaccination-trial_closeup-shot_1col.jpgCOVID-19 vaccine well tolerated, generates immune response

KPWHRI is leading the National Institute of Allergy and Infectious Diseases-sponsored phase 1 trial testing mRNA vaccine.


Brian-Austin-McColl-center_1col.jpg

Decades in the making: A look back at what makes MacColl, MacColl

Upon retirement, MacColl Center co-founder Brian Austin reflects on how the Center became a global pioneer in health care transformation.


Coley_Y_Rebecca_1col.jpg

Benefit of 3D mammogram less with very dense breasts

But for most women, digital breast tomosynthesis improves cancer detection and reduces recalls, writes Dr. Yates Coley.
 


Blog - JAMA Grossman DNA precision population health - 1 column.jpg

Integrating personalized and population medicine

In JAMA, Kaiser Permanente and PCORI experts outline principles for applying genomic data to community health.

 


Larson-LANCET-Preventing-Demetia_1col.jpg

New Lancet report offers hope for preventing dementia

Dr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
 


Coronavirus and protein spike - NIH credit - 1 column.jpg

COVID-19 pandemic research at KPWHRI

Having long tracked infectious diseases and tested vaccines for safety and effectiveness, KPWHRI now focuses on the novel coronavirus.
 


 

 

 



Get social with us

Facebook-icon.pngpage-twitter-icon.png  Linkedin-icon.png  YouTube-icon.png


Suggestions?

Please send comments or suggestions to Communications Director Joan DeClaire at Joan.M.Declaire@kp.org.